Thorsten Lehmann-Lintz

USPTO Granted Patents = 30 (Patent Applications = 5)

CIPO Patents = 5

EPO Patents = 12 (Patent Applications = 13)

Average Co-Inventor Count = 6.7

ph-index = 9

Forward Citations = 277(Granted Patents)

Location History:

Ochsenhausen/Laubach, DE (2003)
Ochsenhausen, DE (2004 - 2015)

Company Filing History:

17 out of 1,537

Boehringer Ingelheim International Gmbh

patents

9 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

4 out of 149

Boehringer Ingelheim Pharma Kg

patents

Years Active: 2003-2015

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9006450 - Compounds, pharmaceutical compositions and uses thereof (2015-04-14),

2. 8901138 - Sulfoximine substituted quinazolines for pharmaceutical compositions (2014-12-02),

3. 8859580 - Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use (2014-10-14),

4. 8853193 - Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions (2014-10-07),

5. 8835472 - Compounds, pharmaceutical compositions and uses thereof (2014-09-16),

6. 8772323 - Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists (2014-07-08),

7. 8765959 - Piperidine derivatives (2014-07-01),

8. 8765780 - Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use (2014-07-01),

9. 8759528 - Piperidine derivatives, pharmaceutical compositions and uses thereof (2014-06-24),

10. 8754079 - Cycloalkyl containing thienopyrimidines for pharmaceutical compositions (2014-06-17),

11. 8648068 - Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions (2014-02-11),

12. 8618132 - Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds (2013-12-31),

13. 8067590 - Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds (2011-11-29),

14. 7858616 - Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments (2010-12-28),

15. 7759347 - 2-benzylaminodihydropteridinones, process for their manufacture and use thereof as medicaments (2010-07-20),

Title: Innovation Extraordinaire: Thorsten Lehmann-Lintz

Introduction:

Thorsten Lehmann-Lintz, a pioneering inventor based in Ochsenhausen, Germany, is renowned for his innovative spirit and unwavering dedication to pushing the boundaries of what is possible in the world of inventions. With an impressive portfolio of 30 patents, he continues to inspire and shape the future of innovation with his groundbreaking work.

Latest Patents:

1. Compounds, Pharmaceutical Compositions and Uses Thereof: Thorsten Lehmann-Lintz's invention focuses on new piperidine derivatives and their application as medicaments, along with methods for therapeutic use and pharmaceutical compositions containing them.

2. Sulfoximine Substituted Quinazolines for Pharmaceutical Compositions: His latest patent involves novel sulfoximine substituted quinazoline derivatives, serving as MNK1 and/or MNK2 kinase inhibitors. These compounds are crucial in treating MNK1 and MNK2 mediated disorders.

Career Highlights:

Throughout his illustrious career, Thorsten Lehmann-Lintz has left an indelible mark on the industry. Notably, he has worked with renowned companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG, where his innovative contributions have significantly advanced the field of pharmaceuticals.

Collaborations:

Thorsten Lehmann-Lintz has had the privilege of collaborating with talented individuals in his field. Among his esteemed coworkers are Gerald Juergen Roth and Armin Heckel, who have shared his passion for pushing the boundaries of innovation and driving progress in the industry.

Conclusion:

In conclusion, Thorsten Lehmann-Lintz's relentless pursuit of innovation, coupled with his groundbreaking patents and collaborations, solidifies his status as a true pioneer in the world of inventions. His work not only reflects his ingenuity and dedication but also serves as a testament to the transformative power of innovation in shaping the future.

This text is generated by artificial intelligence and may not be accurate.